Results

Total Results: 835 records

Showing results for "incident".

121. Vitamin-D-Calcium-Protocol-130611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
     September 13, 2013 - symptoms  Cardiovascular death  Study-specific combinations of cardiovascular events o Cancer (incident … of cardiovascular events • CVD intermediate outcomes (diagnosis of hypertension, blood pressure, incident

122. Quantitative Synthesis: Chapter 2. Presenting Different Effects for Different Data Types (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-2.pdf
     February 01, 2018 - - Not preferred when there is heterogeneity between studies in duration and incident rates - Preferred

123. Osteoporosis-Bone-Fracture Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
     March 01, 2012 - to fractures alone have been nearly $20 billion.2 A recent projection of the burden and costs of incident … another post hoc analysis of data from the same trial found that alendronate reduced the risk of incident

124. An Evidence Review of Active Surveillance in Men with Localized Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_disposition-comments.pdf
     December 01, 2011 - An Evidence Review of Active Surveillance in Men with Localized Prostate Cancer Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?productid=859&pageaction=displayproduct Published Online: December 2011 Comparative Effectiveness Research Review Disposition …

125. Cystic-Fibrosis-Hgh Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
     August 01, 2012 - CER # 23: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis Original release date: October 2010 Surveillance Report 1st Assessment: November, 2011 Surveillance Report 2nd Assessment: August 2012 Key Findings 1st Assessment: • All conclusions for KQ…

126. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
     May 24, 2010 - Consensus also exists for treatment of severe initial incident CDAD with vancomycin.

127. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
     March 01, 2011 - Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE)

128. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
     May 14, 2010 - due to fractures alone have been nearly $20 billion.2 A recent projection of the burden and costs of incident

129. App-D-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
     September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…

130. Development of Quality Criteria To Evaluate Nontherapeutic Studies of Incidence, Prevalence, or Risk Factors of Chronic Diseases: Pilot Study of New Checklists | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/asthma-immunotherapy-2011/research

131. Ch-7-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
     March 29, 2012 - selection in this chapter focus primarily on fixed treatment comparisons when employing the so- called “incident … Pharmacoepidemiological studies that do not restrict analyses to incident episodes of treatments are … of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident

132. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - CER #13: Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer Original release date: February 2008 Surveillance Report: May 2012 Key Findings: • The PIVOT trial was identified, making many of the existing key conclusions out of date. • Key questions 1, 2, and 4 were found t…

133. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - CER #13: Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer Original release date: February 2008 Surveillance Report: May 2012 Key Findings: • The PIVOT trial was identified, making many of the existing key conclusions out of date. • Key questions 1, 2, and 4 were found t…

134. Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
     September 01, 2014 - An assessment of the association between serum 25(OH)D and incident hypertension in 1,211 participants … association, with men in the lowest two quartiles and in the highest quartile at higher risk for incident … hypertension at baseline, at 7 years the trial found the combined supplementation had no effect on incident

135. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_executive.pdf
     July 01, 2011 - Thus, only a low strength of evidence exists that a high AHI (>30 events/hr) is associated with incident … that came to (continued) uncertain conclusions regarding the possible association between AHI and incident … hypertension. • There were 2 studies (1 quality A, 1 quality B) that suggested an association between AHI and incident … The strength of evidence is low that a higher AHI is associated with incident diabetes, though possibly

136. VTE Surveillance Assessment_49_low_SPI (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
     December 01, 2012 - VTE Surveillance Assessment_49_low_SPI     CER # 49:   Comparative effectiveness review of Venous Thromboembolism Prophylaxis in Orthopedic Surgery   Original release date: March 2012 Surveillance Report: December 2012 Key Findings: • Key questions (KQs) 1-4,7-11 are uptodate …

137. Nephropathy-Contrast-Induced Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive.pdf
     October 01, 2015 - 1 Comparative Effectiveness Review Number 156 Contrast-Induced Nephropathy: Comparative Effectiveness of Preventive Measures Executive Summary Background The administration of iodinated contrast media is an essential component of many diagnostic and therapeutic procedures that involve radiologic imaging. One …

138. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/tympanostomy-tubes_research-protocol.pdf
     November 16, 2015 - Untitled   Source: www.effectivehealthcare.ahrq.gov Published online: November 16, 2015 Evidence-based Practice Center Systematic Review Protocol Project Title: Tympanostomy Tubes I. Background and Objectives for the Systematic Review Uncertainty in the comparative effectiveness of tym…

139. S96 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
     October 01, 2007 - ORIGINAL ARTICLE Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* Aaron B. Mendelsohn, PhD,*† Kelly N. Weidenbach, MPH,* Theresa D. Nelson, MS,‡ and Daniel A. Polloc…

140. Musculoskeletal-Complaints-Tests-Children Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
     March 01, 2012 - 1 Comparative Effectiveness Review Number 50 Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children Executive Summary Background Musculoskeletal (MSK) pain is common in children and adolescents, with an estimated prevalence rangin…